Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Sapablursen (Formerly ISIS 702843, IONIS-TMPRSS6-LRx)
Clinical trial NCT04059406 · TERMINATED
Trial details
- NCT number
- NCT04059406
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-24
- Primary completion
- 2023-03-28
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.